PGPaul B. Greenberg

Paul B. Greenberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paul B. Greenberg has a total of 247 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characterizing Research Impact in Ophthalmology: A Scoping Review

    by Olivia V. Waldman, Julia S. Gillette, John C. Lin, Riaz Qureshi, Ingrid U. Scott, Paul B. Greenberg

    The lack of standardization in assessing research impact makes it challenging to accurately define, assess, and differentiate impactful ophthalmic research. This scoping review characterized the most frequently used metrics to evaluate research impact in ophthalmology. Following the updated Joanna Briggs Institute framework and Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines, we reviewed 1100 studies from 1955 to 2023 across CENTRAL, EconLit, Embase, MEDLINE, and Web of Science databases. Included studies were English-language publications that applied at least one metric to evaluate research impact at the article-, author-, institutional-, journal-, or country-level in ophthalmic research. Studies were eligible if they were authored or co-authored by an ophthalmologist or had author affiliation with an ophthalmology department, regardless of journal type. Editorials were excluded. Study quality was assessed using the modified Oxford Center for Evidence-Based Medicine Levels of Evidence, which ranks evidence on a scale from Level 1 (highest quality) to Level 5 (lowest), based on study design and methodological rigor. A total of 77 studies were included; 17 metrics were identified. Citation Count (30%), Publication Count (22%), Impact Factor (17%), and Hirsch index (14%) were the leading metrics. Metrics were primarily (82%) quantitative and most assessed impact at the article- (26%) and the journal-levels (23%). Most studies (94%) had Level 4 evidence. This study highlights the need for a comprehensive and standardized approach to accurately assess ophthalmic research impact.

  • Timing and Determinants of Postinjection Endophthalmitis after First-Time Anti-VEGF Administration

    by Sophia Y. Ghauri, Connor Ross, Joshua B. Gilbert, Daniel J. Hu, Dan Gong, Paul B. Greenberg, Dean Eliott, Tobias Elze, Alice Lorch, Joan W. Miller, et al.


  • Open Access

    Genome-wide association study of dry eye disease reveals shared heritability with systemic comorbidities

    by Bryan R. Gorman, Jaxon J. Huang, Peter B. Barr, Christopher W. Halladay, Cari L. Nealon, Chris Chatzinakos, Michael Francis, Chen Jiang, Million Veteran Program, Paul B. Greenberg, et al.

    Dry eye disease (DED) affects up to 25% of the adult population, with chronic symptoms of pain and dryness often negatively impacting quality of life. The genetic architecture of DED is largely unknown. Here, we develop and validate an algorithm for DED in the Million Veteran Program using a combination of diagnosis codes and prescription records, resulting in 132,657 cases and 352,201 controls. In a multi-ancestry genome-wide association study, we identify ten significant loci in nine susceptibility regions with largely consistent effects across ancestries, including loci linked to synapse maintenance ( EPHA5 , GRIA1 , SYNGAP1 ) and autoimmunity ( BLK ). Phenome-wide scans for genetic pleiotropy indicate substantial genetic correlations of DED with comorbidities, including fibromyalgia, post-traumatic stress disorder, and Sjögren’s disease. Finally, applying genomic structural equation modeling, we derive a latent factor underlying DED and other chronic pain traits which accounts for 51% of the genetic variance of DED.


  • Cataract surgery risk stratification models: a systematic review

    by Chaerim Kang, Angela S. Zhu, Olivia Waldman, T. Michael Kashner, Paul B. Greenberg

    Purpose Risk stratification models can assist cataract surgeons in clinical decision-making by categorizing patients into distinct groups based on their likelihood of complications. In this systematic review, we assess the characteristics of cataract surgery risk stratification models. Methods Using the Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines, we searched six databases (PubMed, OVID, Embase, CINAHL, Cochrane Trials, and Web of Science) in January 2024. We included peer-reviewed, full-text, English-language studies describing models used preoperatively to assess the likelihood of complications in cataract surgery. We excluded letters, editorials, and non-peer-reviewed publications, such as conference abstracts and studies describing predictive models that did not group the patients into distinct risk categories. We constructed a checklist from three frameworks to critically appraise the participants, predictors, and risk of bias in the models. Results Of 4192 articles, eight met the inclusion criteria. Most models were designed for attending surgeons only and for phacoemulsification to predict zonular complications and posterior capsule rupture. The most common risk factors identified in the models were poor patient positioning, advanced age, small pupils, and pseudoexfoliation syndrome. Methodological limitations included the lack of multivariable modeling, standardized outcome measures, and external validation. Conclusion Cataract surgeons should understand the limitations of cataract surgery risk stratification models. Existing models can be improved with more robust methods, the use of standardized metrics, and external validation.


  • Artificial intelligence for diagnosing exudative age-related macular degeneration

    by Chaerim Kang, Jui-En Lo, Helen Zhang, Sueko M Ng, John C Lin, Ingrid U Scott, Jayashree Kalpathy-Cramer, Su-Hsun (Alison) Liu, Paul B Greenberg

    Background Age‐related macular degeneration (AMD) is a retinal disorder characterized by central retinal (macular) damage. Approximately 10% to 20% of non‐exudative AMD cases progress to the exudative form, which may result in rapid deterioration of central vision. Individuals with exudative AMD (eAMD) need prompt consultation with retinal specialists to minimize the risk and extent of vision loss. Traditional methods of diagnosing ophthalmic disease rely on clinical evaluation and multiple imaging techniques, which can be resource‐consuming. Tests leveraging artificial intelligence (AI) hold the promise of automatically identifying and categorizing pathological features, enabling the timely diagnosis and treatment of eAMD. Objectives To determine the diagnostic accuracy of artificial intelligence (AI) as a triaging tool for exudative age‐related macular degeneration (eAMD). Search methods We searched CENTRAL, MEDLINE, Embase, three clinical trials registries, and Data Archiving and Networked Services (DANS) for gray literature. We did not restrict searches by language or publication date. The date of the last search was April 2024. Selection criteria Included studies compared the test performance of algorithms with that of human readers to detect eAMD on retinal images collected from people with AMD who were evaluated at eye clinics in community or academic medical centers, and who were not receiving treatment for eAMD when the images were taken. We included algorithms that were either internally or externally validated or both. Data collection and analysis Pairs of review authors independently extracted data and assessed study quality using the Quality Assessment of Diagnostic Accuracy Studies‐2 (QUADAS‐2) tool with revised signaling questions. For studies that reported more than one set of performance results, we extracted only one set of diagnostic accuracy data per study based on the last development stage or the optimal algorithm as indicated by the study authors. For two‐class algorithms, we collected data from the 2x2 table whenever feasible. For multi‐class algorithms, we first consolidated data from all classes other than eAMD before constructing the corresponding 2x2 tables. Assuming a common positivity threshold applied by the included studies, we chose random‐effects, bivariate logistic models to estimate summary sensitivity and specificity as the primary performance metrics. Main results We identified 36 eligible studies that reported 40 sets of algorithm performance data, encompassing over 16,000 participants and 62,000 images. We included 28 studies (78%) that reported 31 algorithms with performance data in the meta‐analysis. The remaining nine studies (25%) reported eight algorithms that lacked usable performance data; we reported them in the qualitative synthesis. Study characteristics and risk of bias Most studies were conducted in Asia, followed by Europe, the USA, and collaborative efforts spanning multiple countries. Most studies identified study participants from the hospital setting, while others used retinal images from public repositories; a few studies did not specify image sources. Based on four of the 36 studies reporting demographic information, the age of the study participants ranged from 62 to 82 years. The included algorithms used various retinal image types as model input, such as optical coherence tomography (OCT) images (N = 15), fundus images (N = 6), and multi‐modal imaging (N = 7). The predominant core method used was deep neural networks. All studies that reported externally validated algorithms were at high risk of bias mainly due to potential selection bias from either a two‐gate design or the inappropriate exclusion of potentially eligible retinal images (or participants). Findings Only three of the 40 included algorithms were externally validated (7.5%, 3/40). The summary sensitivity and specificity were 0.94 (95% confidence interval (CI) 0.90 to 0.97) and 0.99 (95% CI 0.76 to 1.00), respectively, when compared to human graders (3 studies; 27,872 images; low‐certainty evidence). The prevalence of images with eAMD ranged from 0.3% to 49%. Twenty‐eight algorithms were reportedly either internally validated (20%, 8/40) or tested on a development set (50%, 20/40); the pooled sensitivity and specificity were 0.93 (95% CI 0.89 to 0.96) and 0.96 (95% CI 0.94 to 0.98), respectively, when compared to human graders (28 studies; 33,409 images; low‐certainty evidence). We did not identify significant sources of heterogeneity among these 28 algorithms. Although algorithms using OCT images appeared more homogeneous and had the highest summary specificity (0.97, 95% CI 0.93 to 0.98), they were not superior to algorithms using fundus images alone (0.94, 95% CI 0.89 to 0.97) or multimodal imaging (0.96, 95% CI 0.88 to 0.99; P for meta‐regression = 0.239). The median prevalence of images with eAMD was 30% (interquartile range [IQR] 22% to 39%). We did not include eight studies that described nine algorithms (one study reported two sets of algorithm results) to distinguish eAMD from normal images, images of other AMD, or other non‐AMD retinal lesions in the meta‐analysis. Five of these algorithms were generally based on smaller datasets (range 21 to 218 participants per study) yet with a higher prevalence of eAMD images (range 33% to 66%). Relative to human graders, the reported sensitivity in these studies ranged from 0.95 and 0.97, while the specificity ranged from 0.94 to 0.99. Similarly, using small datasets (range 46 to 106), an additional four algorithms for detecting eAMD from other retinal lesions showed high sensitivity (range 0.96 to 1.00) and specificity (range 0.77 to 1.00). Authors' conclusions Low‐ to very low‐certainty evidence suggests that an algorithm‐based test may correctly identify most individuals with eAMD...


  • The Spectrum of Isolated Retinal Artery Occlusion Secondary to Giant Cell Arteritis

    by Ji Yun Han, Julia S. Gillette, Ingrid U. Scott, Paul B. Greenberg

    We systematically reviewed the literature to investigate the clinical features of isolated arteritic retinal artery occlusion (A-RAO) associated with giant cell arteritis (GCA). The four primary types of A-RAO were central retinal artery occlusion (CRAO), hemi-central retinal artery occlusion (hCRAO), branch retinal artery occlusion (BRAO), and cilioretinal artery occlusion (CLRAO). The most reported presentation was unilateral CRAO, followed by bilateral CRAO, unilateral CLRAO, and bilateral BRAO. Most RAOs were accompanied by typical GCA signs and symptoms, which can help distinguish them from non-arteritic RAOs. When reported, temporal artery biopsy confirmed GCA in most cases. Patients with GCA may present with a broad spectrum of isolated unilateral and bilateral A-RAOs. [ Ophthalmic Surg Lasers Imaging Retina 2024;55:536–540.]


  • Virtual Supervision in Graduate Medical Education: A Systematic Review

    by Chaerim Kang, Christopher J. Shin, Ji Yun Han, Spandana N. Jarmale, Ingrid U. Scott, Karen M. Sanders, Paul B. Greenberg

    Background Despite the increased use of telemedicine, the evidence base on virtual supervision in graduate medical education (GME) is not well described. Objective To systematically review the impact of virtual supervision on trainee education, patient care, and patient satisfaction in Accreditation Council for Graduate Medical Education (ACGME)-accredited specialties. Methods Two databases (PubMed, EMBASE) were searched from database inception to December 2022. Inclusion criteria were peer-reviewed, full-text, English-language articles reporting the use of virtual supervision in GME in ACGME-accredited specialties. Exclusion criteria were studies involving direct supervision, supervisors who were not credentialed physicians, or non-GME trainees. Two investigators independently extracted data and appraised the methodological quality of each study using the Mixed Methods Appraisal Tool (MMAT). The reporting of this systematic review was guided by the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement. Results Of 5278 records identified, 26 studies met the eligibility criteria. Virtual supervision was predominantly utilized in operating rooms and inpatient settings, facilitating clinical examinations or surgical procedures through videoconferencing software in specialties such as dermatology, neurosurgery, and orthopedics. However, some studies reported technical challenges that hindered effective teaching and communication. Based on self-reported surveys, supervisor and trainee satisfaction with virtual supervision was mixed, while patient satisfaction with the care was generally high. The MMAT ratings suggested limitations in sampling strategy, outcome measurement, and confounding factors. Conclusions Virtual supervision was applicable to various specialties and settings, facilitating communication between supervisors and trainees, although there were some technological challenges.


  • Open Access

    The epidemiology of nonpowder firearm-related eye trauma in the United States

    by Julia S. Gillette, Olivia Waldman, Kenan Zaidat, Paul B. Greenberg